Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192992 · ClinicalTrials.gov registry record · NA
Regional Blood Flow During Peripheral Heating
A NA study of Blood Flow, sponsored by San Diego State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06192992: Recruiting NA study of Blood Flow, sponsored by San Diego State University.
NCT06192992 is a NA study of Blood Flow that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 30 participants, below the 50-participant average among 3 other Blood Flow trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06192992, a NA study of Blood Flow, is actively recruiting participants, sponsored by San Diego State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood flow through the popliteal, brachial, and carotid arteries during peripheral heating of the feet
Conditions Studied
Interventions
- OTHER Sham
- OTHER Peripheral heating of 2 feet
Study Locations (1)
California
- Jeff Moore - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What NCT06192992 shows while recruiting
NCT06192992 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 50-participant average among 3 other Blood Flow trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Blood Flow appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT06192992 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06192992 about?
NCT06192992 is a clinical study titled "Regional Blood Flow During Peripheral Heating". Blood flow through the popliteal, brachial, and carotid arteries during peripheral heating of the feet
What is the current status of trial NCT06192992?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-05-31. Estimated completion is 2025-05-31.
What conditions does trial NCT06192992 study?
This clinical trial studies the following conditions: Blood Flow.
What interventions are being tested in trial NCT06192992?
The interventions under investigation include: Sham (OTHER), Peripheral heating of 2 feet (OTHER).
Who is sponsoring clinical trial NCT06192992?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06192992 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Flow
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
RECRUITING · NA
-
Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome
ACTIVE NOT RECRUITING · NA
-
Early Neurovascular Adaptations in Aging Women
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI